No profile data available.
Prime Medicine, Inc. (PRME) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Cambridge, United States, with about 146 full-time employees.
It reported revenue of $4.63 million for fiscal year 2025, up 55.3% from fiscal year 2024, and net income of -$201.14 million. Its market capitalization was $723.69 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States.
Prime Medicine reported $4.63 million in revenue for fiscal year 2025, up 55.3% from $2.98 million in fiscal year 2024.
$723.69 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include MoonLake Immunotherapeutics (MLTX), Jade Biosciences, Inc. (JBIO), Sana Biotechnology, Inc. (SANA), Emergent BioSolutions Inc. (EBS).